Ledger.Open graph →
SEC Form D · Amendment · filed October 31, 2019

Lung Therapeutics, Inc

Offering
$38.7M
Sold
$38.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Austin, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

R. A. Session · Dallas, TXDirectorRobert B. Mills · Naples, FLDirectorSteven B. Idell · Tyler, TXDirectorAaron G. Fletcher · Fort Worth, TXDirectorEleonore Dachicourt · New York, NYDirectorSai Venkata Rao Avasarala · Frisco, TXDirectorHamish Cameron · London, United KingdomDirectorPrabhakaran T. Prakasam · Fort Myers, FLDirectorJames B. Windsor · Austin, TXExec · DirectorTimothy Chklovski · Los Angeles, CADirectorCharlie Baker · Winooski, VTDirectorArthur Heinmaa · Toronto, Ontario, CanadaDirectorCharles Lannon · Toronto, Ontario, CanadaDirectorJames B. Windsor · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗